Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fueling metabolic disruption via FMD to boost chemotherapy in TNBC
    Editorial

    Goncalves, M. D.; Iyengar, N. M.
    Cell Metabolism (2025)

    Fulltext@MSK | Save
  • Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor–positive human epidermal growth factor receptor 2–negative breast cancer: Primary results from TROPION-Breast01
    Journal Article

    Bardia, A.; Jhaveri, K.; Im, S. A.; Pernas, S.; De Laurentiis, M.; Wang, S.; Martínez Jañez, N.; Borges, G.; Cescon, D. W.; Hattori, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Correlation between disease-free survival endpoints and overall survival in elderly patients with early-stage HER2-negative breast cancer: A SEER-medicare analysis
    Journal Article

    Earla, J. R.; Kurian, A. W.; Kponee-Shovein, K.; Mahendran, M.; Song, Y.; Hua, Q.; Hilts, A.; Sun, Y.; Hirshfield, K. M.; Robson, M.; more...
    Advances in Therapy (2025)

    Fulltext@MSK | Save
  • Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
    Journal Article

    DeMichele, A.; Dueck, A. C.; Hlauschek, D.; Martin, M.; Burstein, H.; Pfeiler, G.; Zdenkowski, N.; Wolff, A.; Bellet-Ezquerra, M.; Winer, E.; more...
    Breast Cancer Research (2025)

    Fulltext@MSK | Save
  • Survival among patients with ERBB2-positive metastatic breast cancer and central nervous system disease
    Journal Article

    Ferraro, E.; Reiner, A. S.; Bou Nassif, R.; Tosi, U.; Brown, S.; Zeller, S.; Dang, C. T.; Seidman, A. D.; Moss, N. S.
    JAMA Network Open (2025)

    Fulltext@MSK | Save
  • Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: A secondary analysis of a randomized trial
    Journal Article

    Iyengar, N. M.; Scott, J. M.; Lee, J.; Lavery, J. A.; Foug, K. L.; Lee, C. P.; Michalski, M. G.; Chun, S. S.; Harrison, J.; Moskowitz, C. S.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Inavolisib therapy in advanced breast cancer - The authors reply
    Correspondence

    Turner, N. C.; Thanopoulou, E.; Jhaveri, K. L.
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Loss of KMT2C or KMT2D primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters
    Journal Article

    Wang, N.; Pachai, M. R.; Li, D.; Lee, C. J.; Warda, S.; Khudoynazarova, M. N.; Cho, W. H.; Xie, G.; Shah, S. R.; Yao, L.; more...
    Nature Genetics (2025)

    Fulltext@MSK | Save
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Expanding the use of T-DXd in metastatic HR-positive breast cancer: Where are we now?
    Editorial

    Drago, J.; Modi, S.
    Nature Reviews Clinical Oncology (2025)

    Fulltext@MSK | Save